Financial statements Inngen Laboratorium Badań Genetycznych
Balance sheet data of INNGEN LABORATORIUM BADAŃ GENETYCZNYCH
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 540 041,88 | 687 982,84 | 672 687,30 | 600 245,61 | 752 601,81 | 1 703 434,34 |
| A. Fixed assets | 180 127,35 | 165 741,59 | 121 870,22 | 146 354,72 | 483 112,46 | 481 981,55 |
| B. Current assets | 359 914,53 | 522 241,25 | 550 817,08 | 453 890,89 | 269 489,35 | 1 221 452,79 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 540 041,88 | 687 982,84 | 672 687,30 | 600 245,61 | 752 601,81 | 1 703 434,34 |
| A. Equity | 525 837,91 | 659 049,75 | 410 655,92 | 399 164,90 | 69 541,23 | 155 137,27 |
| B. Liabilities and provisions for liabilities | 14 203,97 | 28 933,09 | 262 031,38 | 201 080,71 | 683 060,58 | 1 548 297,07 |
| I. Long-term liabilities | 0,00 | 0,00 | 180 000,00 | 37 500,00 | 67 117,73 | 21 974,68 |
| II. Short-term liabilities | 14 203,97 | 28 933,09 | 82 031,38 | 162 200,71 | 615 942,85 | 1 526 322,39 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.